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Abstract
OBjECTIVE: To investigate the effect of Chinese
medicines using the warming Yang and removing
blood stasis method on levels of matrix metallopro-
teinases (MMPs)/tissue inhibitor metalloproteinas-
es (TIMPs) secreted by cultured endometrial cells
from patients with endometriosis.
METHODS: Ectopic and eutopic endometrial cells
obtaind from 15 endometriosis patients were cul-
tured in vitro , and divided randomly into five
groups: high dose; moderate dose; low dose;
nemestran; blank control. The three dose groups
were treated with a decoction prepared according
to the principle of warming Yang and removing
blood stasis; nemestran and 0.9% NaCl were admin-
istered to the nemestran group and balnk control
group, respectively. Eutopic endometrial cells ob-
taind from 10 hysteromyoma patients were cul-
tured in vitro，as the normal control group，0.9% Na-
Cl were administered to the normal control group.
Cell culture supernatants were collected and levels
of matrix metalloproteinase-1 (MMP-1), matrix me-
talloproteinase-2 (MMP-2), matrix metalloprotein-
ase-9 (MMP-9), tissue inhibitor metalloproteinase-1
(TIMP-1) and tissue inhibitor metalloproteinase -2
(TIMP-2) detected by enzyme-linked immuno sor-
bent assay (ELISA).
RESULTS: Compared with the normal control
group, levels of MMP-1, MMP-2, and MMP-9 in eu-
topic and ectopic endometrium cell supernatants
in the blank control group were increased, whereas
levels of TIMP-1 and TIMP-2 were decreased (P <
0.05). Compared with the blank control group, lev-
els of MMP-1 and MMP-2 in ectopic and eutopic en-
dometrium cell supernatants cultured in low-dose,
middle-dose, and high-dose groups were de-
creased, whereas levels of TIMP-1 and TIMP-2 were
increased significantly (P < 0.05).
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CONCLUSION: The warming Yang and removing
blood stasis method affects expression of MMPs
and TIMPs.
© 2015 JTCM. All rights reserved.
Key words: Endometriosis; Matrix metalloprotein-
ases; Tissue inhibitor of metalloproteinases; Warm-
ing Yang; Removing blood stasis
INTRODUCTION
The incidence of endometriosis (EMS) in women of
childbearing age is about 5%-10%. EMS is a relatively
common gynecologic disease characterized by the pro-
liferation, invasion and metastasis of cells, as well as re-
currence, and malignancy.1 Studies have shown that ma-
trix metalloproteinases (MMPs) and tissue inhibitors
of matrix metalloproteinases (TIMPs) are associated
with EMS onset.2,3
MMPs are a group of proteases that can degrade al-
most all components of the extracellular matrix (ECM;
e.g., collagen, protein-fiber connections, proteins, poly-
saccharides). MMPs are a class of highly conserved en-
zymes in nature. TIMPs are a family of natural, specific
inhibitory factors of MMPs that can combine with the
corresponding MMP preferment or active enzyme to
inhibit MMP activity. These two factors have impor-
tant roles in maintenance of the stability and structural
integrity of the internal environment of the ECM.4,5
Studies have shown that disorder of MMPs/TIMPs can
promote destruction and degradation of the peritoneal
ECM and prompt the development of EMS.6,7 Howev-
er, the occurrence, development, and prognosis of
EMS warrants further study because these factors are
incompletely understood.
EMS treatment with Traditional Chinese Medicine
(TCM) has gained increasing attention in recent years.
Main pathologic change of EMS is periodic bleeding
of the ectopic endometrium (known as“blood circulat-
ing out of vessels”in TCM). Numerous scholars be-
lieve that the basic pathogenesis of EMS (in terms of
TCM theory) is blood stasis; treatment is based on pro-
motion of blood circulation and removal of blood sta-
sis. However, the clinical outcome for some EMS pa-
tients is not significant, which suggests that the patho-
genesis and therapeutic principle of TCM in EMS mer-
its further investigation.
Clinical observations as well as ancient and modern lit-
erature suggest that the pathogenesis of EMS in terms
of TCM is Yang deficiency and blood stasis. Thus,
EMS treatment should consider both of these aspects.
In clinics, warming Yang and removing stasis (by con-
sumption of Dangguisini soup) has been applied, re-
placing the convention of activating blood and remov-
ing stasis for EMS treatment. Results have shown that
the curative effect has been obviously improved (espe-
cially in terms of relieving dysmenorrheal and chronic
pelvic pain) for EMS patients.
In the present study, the effect of warming Yang and re-
moving blood stasis on cultured endometrial cells in
EMS patients was observed. Pathogenesis of EMS, as
well as the therapeutic effect of warming Yang and re-
moving blood stasis on EMS, was investigated further.
METHODS
Subjects
Twenty-one cases of EMS patients and 12 cases of Hys-
teromyoma patients were recruited from the Depart-
ment of Gynecology in Guangdong Provincial Tradi-
tional Chinese Medicine Hospital (Guangdong, Chi-
na) from October 2010 to August 2012. ALL patients
were underwent surgery，the ectopic endometrium and
eutopic endometrium in patient were gain and cul-
tureed in vitro. The cultivation of 15 cases of EMS and
10 cases of Hysteromyoma patients were successful，
The average age of the recruited patients was (32 ± 4)
years. Hormonal drugs had not been used within 3
months in all cases.
Preparation of Chinese medicines for warming Yang
and removing blood stasis
Chinese medicines used for warming Yang and remov-
ing blood stasis were purchased from Kangmei Pharma-
ceutical Company (Puning, China) and were: Danggui
(Radix Angelicae Sinensis), 1.5 × 104 mg; Guizhi (Ramu-
lus Cinnamomi), 1.0 × 104 mg; Baishao (Radix Paeoniae
Alba), 1.5 × 104 mg; Xixin (Herba Asari Mandshurici),
3.0 × 103 mg; honey-fried Gancao (Radix Glycyrrhi-
zae), 1.0 × 104 mg; Tongcao (Medulla Tetrapanaicis),
1.0 × 104 mg; Dazao (Fructus Jujubae), 1.0 × 104 mg;
Wuyao (Radix Linderae Aggregatae), 1.0 × 104 mg; Fuzi
(Radix Aconiti Lateralis Preparata), 6.0 × 103 mg; Ganji-
ang (Rhizoma Zingiberis), 9.0 × 103 mg. Total weight of
these ingredients was 9.6 × 104 mg. Ingredients were
boiled in a ceramic frying pan and centrifuged（1699 × g
for 10 min, Again, 3999 × g for 10 min）to obtain a
crude drug concentration of 700 mg/mL in liquid；
and then stored in a sterile vessel. Phosphate-buffered
saline was used to dilute nemestran to 8 mmol/L.
Culture and identification of cultured endometrial
cells
Culture and identification of cultured endometrial cells
were undertaken according to a method reported previ-
ously,8 with slight modification. Obtained tissue was
shredded and washed with Dulbecco's modified Ea-
gle's media: Nutrient Mixture F-12 ("FD medium";
Sigma-Aldrich, Saint Louis, MO, USA). After centrifu-
gation, a double-enzyme digestion liquid was added in
an incubator. After washing, centrifugation and dis-
carding supernatants, the mixture was filtered. The fil-
trate contained mainly interstitial cells, with clusters of
glandular cells on the filter. Cells in the filtrate were in-
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oculated in six-well plates with coverslips in a culture
bottle (concentration, 5-6 × 105 cell/mL), followed by
culture in an incubator (at 37 ℃ in an atmosphere of
5% CO2). After cells had covered 90% of the wall of
the culture bottle, passaging was undertaken. The me-
dium was discarded, and then 5 mL of 0.25% trypsin
(Cusabio Biotech Co., Ltd., Wuhan, China) was add-
ed, followed by incubation at 37 ℃ . Cells on the wall
of the culture bottle were "blown down" using a suc-
tion tube. After centrifugation, the supernatant was dis-
carded. FD medium containing 10% fetal bovine se-
rum (Cusabio Biotech Co., Ltd., Wuhan, China) and
penicillin(Cusabio Biotech Co., Ltd., Wuhan, China)
was added to precipitated cells. After "blowing", the
cell suspension was obtained, and the concentration ad-
justed to 1-2.5×105 cell/mL. Cells were inoculated into
a 96-well culture plate (Cusabio Biotech Co., Ltd.,
Wuhan, China), followed by culture in an incubator
(at 37 ℃ in an atmosphere of 5% CO2). The medium
was renewed once for every 2-3 days until cell aggrega-
tion. Vimentin, keratin, and prolactin were used to
identify cultured endometrial cells .9 Changes in cell
morphology were documented.
Cell grouping and administration
Third-generation cultured endometrial cells were ob-
tained and seeded in 96-hole plates (1×105/mL). When
about 90% of cultured cells had aggregated, those
from the EMS patients were divided randomly into
five groups using the random number table method:
high-dose, medium-dose, low-dose, nemestran, blank
control (3 cells per hole). According to preliminary test
results, the high-dose, medium-dose and low-dose
warming Yang and removing blood stasis groups were
treated with 14.0, 1.4 and 0.7 mg/mL TCM, respec-
tively. The nemestran group were treated with 8 mmol/
L nemestran (Sanofi-Aventis, Paris, France). The blank
control group were treated with physiologic (0.9% )
NaCl. Those from the Hysteromyoma patients were
treated with physiologic (0.9% ) NaCl, as the normal
control group. After 24 h of incubation, cell culture su-
pernatants were collected and stored at－70℃. All sam-
ples were evaluated by an enzyme-linked immunosor-
bent assay (ELISA; Bender MedSytems, Vienna, Aus-
tria).
Detection indicators and methods
Contents of MMP-1, MMP-2, MMP-9, TIMP-1, and
TIMP-2 in cell culture supernatants were detected by
ELISA in accordance with kit instructions. All laborato-
ry reagents were purchased from Cusabio Biotech Co.,
Ltd. (Wuhan, China).
Statistical analyses
Statistical analyses were carried out using SPSS v17.0
(IBM, Armonk, NY, USA). Measurement data with a
normal distribution were expressed as the mean ± stan-
dard deviation ( xˉ ± s). Differences between multiple
groups were compared with analysis of variance using
SPSS v17.0. Differences between two groups were
compared using the Mann-Whitney U-test. P < 0.05
was considered significant.
RESULTS
Changes in cell morphology
Cultured endometrial cells in the ectopic endometrium
and eutopic endometrium grew well, and most of
them had normal morphology (Figure 1A, 1B). In
warming Yang and removing blood stasis groups,
Figure 1 Morphology of endometrial stromal cells (×40 magnification)
A: the blank control group; B: the normal control group, C: the low-dose group; D: the moderate-dose group; E: the high-dose
group; F: the nemestran group. The high-dose, medium-dose and low-dose warming Yang and removing blood stasis groups
were treated with 14.0, 1.4 and 0.7 mg/mL TCM for 24 h, respectively. The nemestran group was treated with 8 mmol/L nemestran
for 24 h. The blank control group and the normal control group were treated with physiologic (0.9%) NaCl for 24 h. TCM: Tradition-
al Chinese Medicine.
A B C
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with increasing dose, the number of normal cells de-
creased, and the number of cells that exhibited
shrinkage, vacuolization, fat bodies, mitochondrial
swelling and even disintegration increased (Figure
1C-1E). The number of normal cells in the nemes-
tran group also decreased, and had a similar morphol-
ogy (Figure 1F).
Effect of warming Yang and removing blood stasis on
levels of MMP-1 and MMP-2
Levels of MMP-1 and MMP-2 in the ectopic endome-
trium and eutopic endometrium of the blank control
group were higher than those of the normal control
group (P < 0.05) (Table 1). Levels of MMP-1 in the ec-
topic endometrium and eutopic endometrium, as well
as MMP-2 levels in the eutopic endometrium, in medi-
um-dose, high-dose, and nemestran groups were lower
than those in the blank control group (P < 0.05).
MMP-2 levels in the ectopic endometrium in the
high-dose group and nemestran group were lower than
those in the blank control group (P < 0.05), hower
than those in the normal control group, but the differ-
ence was not significant (P > 0.05). Levels of MMP-1
and MMP-2 in the eutopic endometrium in the
low-dose group were lower than those in the blank con-
trol group, but the difference was not significant (P >
0.05) (Table 1). These results suggested that EMS pa-
tients may have increased expression of MMP-1 and
MMP-2 in the ectopic endometrium and eutopic endo-
metrium.The warming Yang and removing blood stasis
method may decrease MMP-1 and MMP-2 levels in
the ectopic endometrium and eutopic endometrium.
With the increase of drug concentration, the inhibition
effect was enhanced, which was dose depend.
Effect of eutopic and ectopic endometrial in vitro
culture on MMP-9 levels in cell supernatants by the
warming Yang and removing blood stasis method
MMP-9 levels in the eutopic endometrium and ectopic
endometrium of the blank control group were higher
than those in the normal control group (P < 0.05) (Ta-
ble 2). MMP-9 levels in the eutopic endometrium in
the medium-dose group and nemestran group were
lower than those in the blank control group (P < 0.05).
Howevre, MMP-9 levels in the eutopic endometrium
in high-dose and low-dose groups were less than those
in the blank control group, but this difference was not
significant (P > 0.05). MMP-9 levels in the ectopic en-
dometrium in high-dose, medium-dose, and low-dose
groups were similar with those in the control group,
Compared with the control group, the difference was
not significant (P > 0.05) (Table 2). However, MMP-9
Group
Low dose
Medium dose
High dose
Nemestran
Blank control
Normal control
n
15
15
15
15
15
10
MMP-9 level in the eutopic endometrium
88±21
61±7a
89±21
44±7a
99±15
43±22a
MMP-9 level in the ectopic endometrium
99±16
100±18
99±12
51±7a
99±18
-
Table 2 Effect of eutopic and ectopic endometrial in vitro culture on MMP-9 levels in the warming Yang and removing blood stasis
method (ng/mL, xˉ ± s )
Notes: the high-dose, medium-dose and low-dose warming Yang and removing blood stasis groups were treated with 14.0, 1.4 and 0.7 mg/
mL TCM for 24 h, respectively. The nemestran group was treated with 8 mmol/L nemestran for 24 h. The blank control group and the
normal control group were treated with physiologic (0.9%) NaCl for 24 h. Compared with the blank control group, aP < 0.05. TCM: Tra-
ditional Chinese Medicine; MMP: metalloproteinase.
Table 1 Effect of the warming Yang and removing blood stasis method on levels of MMP-1 and MMP-2 from stromal cells (ng/mL,
xˉ ± s )
Notes: the high-dose, medium-dose and low-dose warming Yang and removing blood stasis groups were treated with 14.0, 1.4 and 0.7 mg/
mL TCM for 24 h, respectively. The nemestran group was treated with 8 mmol/L nemestran for 24 h. The blank control group and the
normal control group were treated with physiologic (0.9%) NaCl for 24 h. Compared with the blank control group, aP < 0.05, following
are the same. TCM: Traditional Chinese Medicine; MMP: metalloproteinase.
Group
Low dose
Medium dose
High dose
Nemestran
Blank control (0.9% NaCl, 24 h)
Normal control
n
15
15
15
15
15
10
MMP-1 level in eu-
topic endometrium
137±40
70±17a
43±24a
45±17a
150±45
40±13a
MMP-1 level in ec-
topic endometrium
136±20
88±12a
45±16a
45±16a
133±18
-
MMP-2 level in eu-
topic endometrium
50±11
43±8a
40±8a
40±9a
55±6
39±8a
MMP-2 level in ec-
topic endometrium
59±19
55±17
40±10a
42±9a
60±18
-
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levels in the ectopic endometrium in the nemestran
group were lower than those in the blank control
group (P < 0.05). These data showed that EMS pa-
tients may have increased expression of MMP-9 in the
ectopic endometrium and eutopic endometrium.
Nemestran may decrease MMP-9 levels in the ectopic
endometrium and eutopic endometrium, but the
warming Yang and removing blood stasis method had
little effect on endometrial levels of MMP-9.
Effect of eutopic and ectopic endometrial in vitro
culture on levels of TIMP-1 and TIMP-2 in cell
supernatants by the warming Yang and removing
blood stasis method
Levels of TIMP-1 and TIMP-2 in the ectopic endome-
trium and eutopic endometrium of the blank control
group were lower than those in the normal control
group (P < 0.05) (Table 3). Levels of TIMP-1 and
TIMP-2 in the eutopic endometrium in medium-dose,
high-dose, and nemestran groups were higher than
those of the blank control group (P < 0.05). Levels of
TIMP-1 and TIMP-2 in the ectopic endometrium in
high-dose group and nemestran groups were higher
than those in the blank control group (P < 0.05).
TIMP-2 levels in the eutopic endometrium from the
low-dose group, and TIMP-2 levels in the ectopic en-
dometrium from the medium-dose group, were also
higher than those in the blank control group (P <
0.05) (Table 3). These data showed that patients with
EMS exhibited decreased expression of TIMP-1 and
TIMP-2 in eutopic and ectopic endometrium. The
warming Yang and removing blood stasis method and
nemestran method could increase expression of
TIMP-1 and TIMP-2 in the ectopic endometrium and
eutopic endometrium. The increase in the concentra-
tion of the culture medium of the warming Yang and
removing blood stasis method promoted secretion of
TIMP-1 and TIMP-2 in stromal ectopic endometrial
cells, and this effect was dose-dependent.
DISCUSSION
MMPs are a class of endopeptidases dependent on
Zn2 + , Ca2 + , and Mg2 + . MMPs have 30 members that
can participate in the cyclical growth, differentiation,
and collapse of endometrial cells in childbearing-age
women.10,11 The ectopic endometrium of patients with
EMS can secrete MMPs. "Planting" of the ectopic en-
dometrium involves invasion of surrounding tissues to
cause the collapse and reconstruction of the ECM.9,12,13
Disorders in the relationship between MMPs and
TIMPs can promote the degradation and destruction
of the peritoneal ECM and, consequently, prompt
EMS development.14-17 Stilly and colleagues found that
MMP-1/TIMP-1 levels could induce endometrial tis-
sue to increase the chance of cell invasion, and to have
important roles in EMS development.18 We showed
that expression of MMP-1, MMP-2, and MMP-9 in
the ectopic endometrium and eutopic endometrium in
the control group was significantly higher than that in
the control group. Levels of TIMP-1 and TIMP-2 in
the control group were significantly lower than those
in the control group. These results are consistent with
previous studies.19,20 Regulation of MMPs and their in-
hibitors is a complex and multiple-stage process affect-
ed by many factors that can control gene transcription
and enzyme activation. Steroid hormones, cytokines,
and growth factors can regulate the secretion and ex-
pression of MMPs and TIMPs.21,22
Bruner et al 23 found that inhibition of MMP secretion
prevented the formation of ectopic lesions in nude
mice. These enzymes were chosen because of the bio-
logical properties of endometrial cells: they are good
markers in clinical observations regarding therapeutic
effects. The present study showed that warming Yang
and removing blood stasis could reduce the number of
EMS patients with ectopic disorders, and involved ex-
pression of MMP-1, MMP-2, TIMP-1 and TIMP-2.
Thus, the mechanism of action of the warming Yang
and removing blood stasis method may have involved
restoration of the balance of MMPs/TIMPs levels to
suppress cellular invasion in the ectopic endometrium
and eutopic endometrium. This method could also
change the endometrial biologic characteristics of EMS
patients, thereby reversing pathologic processes. Such
Group
Low dose
Medium dose
High dose
Nemestran
Blank control
Normal control
n
15
15
15
15
15
10
TIMP-1 level in the
eutopic endometrium
10.2±1.5
21.7±3.4a
24.8±5.0a
25.0±4.2a
10.4±1.1
25.6±2.7a
TIMP-1 level in the
ectopic endometrium
12.5±2.7
13.2±2.4
26.1±4.8a
26.3±5.1a
12.7±2.6
-
TIMP-2 level in the
eutopic endometrium
11.4±3.4a
13.3±6.8a
22.6±8.8a
22.8±9.3a
8.6±3.4
15.5±5.9a
TIMP-2 level in the ec-
topic endometrium
6.2±1.6
11.1±3.3a
16.7±2.4a
16.6±3.1a
6.1±1.9
-
Table 3 Effect of eutopic and ectopic endometrial in vitro culture on levels of TIMP-1 and TIMP-2 by the warming Yang and remov-
ing blood stasis method (ng/mL, xˉ ± s )
Notes: the high-dose, medium-dose and low-dose warming Yang and removing blood stasis groups were treated with 14.0, 1.4 and 0.7 mg/
mL TCM for 24 h, respectively. The nemestran group was treated with 8 mmol/L nemestran for 24 h. The blank control group and the
normal control group were treated with physiologic (0.9%) NaCl for 24 h. Compared with the blank control group, aP < 0.05. TCM: Tra-
ditional Chinese Medicine; TIMP: tissue inhibitor of metalloproteinase.
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concepts merit verification in rigorous, prospective,
double-blind randomized controlled clinical trials.
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